Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Debridement & negative-pressure wound therapy · Texas | Debridement & negative-pressure wound therapy · Alaska | |
|---|---|---|
| Surgeons, 2024 | 1,025 | 11 |
| Medicare fee-for-service cases | 283,370 | 2,366 |
| Growth since 2019 (Medicare FFS) | +3.6%/yr | −11%/yr |
| Forecast cases (Medicare FFS) | 394,700 in 2030 | 2,680 in 2030 |
| Forecast growth | +5.7%/yr to 2030 | +2.1%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 125.0 | 19.6 |
| Medicare Advantage share | 59% | 3% |
| Out of hospital | 51% (+13 pts since 2019) | 19% (−12 pts since 2019) |
| Cases per surgeon | 276 | 215 |
| Top 10 surgeons' share | 16% | 99% |
| Surgeons growing | 174 | 0 |
| New since the base year | 409 | 7 |
| Likely to stop billing it | 181 by 2026 | 2 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $1,556 | $3,931 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.